Cargando…

Safety and efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine antiretroviral therapy between HIV-infected patients with baseline CD4 <50 versus CD4 ≥ 50 cells/mm(3)

BACKGROUND: Antiretroviral therapy (ART) with a generic fixed-dose combination (FDC) of stavudine (d4T)/lamivudine (3TC)/nevirapine (NVP) is widely used in developing countries. The clinical data of this FDC among very advanced HIV-infected patients is limited. METHODS: A retrospective cohort study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manosuthi, Weerawat, Chimsuntorn, Sukanya, Likanonsakul, Sirirat, Sungkanuparph, Somnuek
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828738/ https://www.ncbi.nlm.nih.gov/pubmed/17352834 http://dx.doi.org/10.1186/1742-6405-4-6

Ejemplares similares

Durability of Stavudine, Lamivudine and Nevirapine among Advanced HIV-1 Infected Patients with/without Prior Co-administration of Rifampicin: A 144-week Prospective Study
por: Manosuthi, Weerawat, et al.
Publicado: (2008)

Renal impairment after switching from stavudine/lamivudine to tenofovir/lamivudine in NNRTI-based antiretroviral regimens
por: Manosuthi, Weerawat, et al.
Publicado: (2010)

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole
por: Manosuthi, Weerawat, et al.
Publicado: (2007)

Steady State Bioequivalence of Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine in HIV-Infected Ugandan Adults
por: Byakika-Tusiime, Jayne, et al.
Publicado: (2008)

Safety and tolerability of nevirapine-based antiretroviral therapy in HIV-infected patients receiving fluconazole for cryptococcal prophylaxis: a retrospective cohort study
por: Manosuthi, Weerawat, et al.
Publicado: (2005)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

Long-term treatment outcomes of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who experienced NRTI and NNRTI failure
por: Manosuthi, Weerawat, et al.
Publicado: (2012)

Effects of CYP2B6 G516T polymorphisms on plasma efavirenz and nevirapine levels when co-administered with rifampicin in HIV/TB co-infected Thai adults
por: Uttayamakul, Sumonmal, et al.
Publicado: (2010)

Integrated therapy for HIV and tuberculosis
por: Manosuthi, Weerawat, et al.
Publicado: (2016)

A Model and Risk Score for Predicting Nevirapine-Associated Rash among HIV-infected Patients: In Settings of Low CD4 Cell Counts and Resource Limitation
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2009)

The NRTIs Lamivudine, Stavudine and Zidovudine Have Reduced HIV-1 Inhibitory Activity in Astrocytes
por: Gray, Lachlan R., et al.
Publicado: (2013)

Treatment outcomes and plasma level of ritonavir-boosted lopinavir monotherapy among HIV-infected patients who had NRTI and NNRTI failure
por: Manosuthi, Weerawat, et al.
Publicado: (2009)

Lack of transmission among healthcare workers in contact with a case of Middle East respiratory syndrome coronavirus infection in Thailand
por: Wiboonchutikul, Surasak, et al.
Publicado: (2016)

HLA-Cw*04 allele associated with nevirapine-induced rash in HIV-infected Thai patients
por: Likanonsakul, Sirirat, et al.
Publicado: (2009)

Efficacy of Rilpivirine-Based Regimens as Switch Therapy From Nevirapine-Based Regimens in Human Immunodeficiency Virus-Infected Patients With Virological Suppression: A Randomized Controlled Trial
por: Petchkum, Porkaew, et al.
Publicado: (2019)

$^{98}_{48}Cd_{50}$- the two-proton hole spectrum in $^{100}_{50}Sn_{50}$
por: Górska, M, et al.
Publicado: (1997)

SIDE effects associated with use of nevirapine in HIV treatment naïve patients with respect to baseline CD4 count
por: Shevkani, Manoj, et al.
Publicado: (2010)

Rapid CD4 decline after interruption of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy in a resource-limited setting
por: Sungkanuparph, Somnuek, et al.
Publicado: (2007)

Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines
por: Kageyama, Seiji, et al.
Publicado: (2019)

Virological failure of staggered and simultaneous treatment interruption in HIV patients who began Efavirenz-based regimens after allergic reactions to nevirapine
por: Siripassorn, Krittaecho, et al.
Publicado: (2013)

Compromised CD4:CD8 ratio recovery in people living with HIV aged over 50 years: an observational study
por: Francis‐Morris, A, et al.
Publicado: (2019)

Brain antioxidants and hippocampal microanatomical alterations following the administration of Efavirenz/Lamivudine/Tenofovir disoproxil fumarate and Lamivudine/Nevirapine/Zidovudine in adult male Wistar rats
por: Edagha, Innocent A., et al.
Publicado: (2022)

Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes
por: Mocroft, A
Publicado: (2010)

More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV Cohort
por: Rokx, Casper, et al.
Publicado: (2014)

Can We Improve Stavudine's Safety Profile in Children? Pharmacokinetics of Intracellular Stavudine Triphosphate with Reduced Dosing
por: Innes, Steve, et al.
Publicado: (2018)

Effectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed Viremia
por: Llibre, Josep M., et al.
Publicado: (2015)

Post-dispensing stability surveillance: Stavudine
por: Naidoo, Kamsaladevi K., et al.
Publicado: (2009)

Technical note - Pick up ∅ 140 mm C-2798-50-2
por: Oreberg, P E
Publicado: (1987)

Technical note - Pick up ∅ 172 mm C-2799-50-2
por: Oreberg, P E
Publicado: (1987)

Technical note - Pick up ∅ 243 mm C-2800-50-2
por: Oreberg, P E
Publicado: (1987)

Laparoscopic parenchyma-sparing liver resection for large (≥ 50 mm) colorectal metastases
por: Aghayan, Davit L., et al.
Publicado: (2022)

Epidemiology and Relationships between CD4+ Counts and Oral Lesions among 50 Patients Infected with Human Immunodeficiency Virus
por: Berberi, Antoine, et al.
Publicado: (2015)

Formulation and evaluation of floating matrix tablet of stavudine
por: Prajapati, Pankaj H, et al.
Publicado: (2012)

Failure of asnis iii 5.0 mm cannulated screw: a case report
por: Chen, A, et al.
Publicado: (2010)

Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder
por: Cheema, Muhammad Raza, et al.
Publicado: (2016)

High-Power Fiber Laser Cutting for 50-mm-Thick Cement-Based Materials
por: Seo, Youngjin, et al.
Publicado: (2020)

Machine development du 50.4-1970
por: Henny, L, et al.
Publicado: (1970)

beta-estradiol attenuates the anti-HIV-1 efficacy of Stavudine (D4T) in primary PBL
por: Zhang, Mingjie, et al.
Publicado: (2008)

CD4 response, lipid changes and liver outcome in 506 patients receiving nevirapine-based regimens for a median of 9 years
por: Podzamczer, D, et al.
Publicado: (2010)

Treatment outcomes of oral sitafloxacin in acute complicated urinary tract infection and pyelonephritis
por: Manosuthi, Weerawat, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1jp4og4m4v4dhscapkrkp4e3i9